Bigora Sian has filed 22 insider transactions across 1 company since January 2024.
Most recent transaction: a purchase of 1971 shares of Processa Pharmaceuticals, Inc. ($PCSA) on April 30, 2026.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 30, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | P | Common Stock | 1971 | $2.71 | 7,748.0000 | 56,644,223 | 34.12% | 0.00% |
| April 30, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | P | Common Stock | 1986 | $2.69 | 7,763.0000 | 56,644,223 | 34.38% | 0.00% |
| April 15, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | P | Common Stock | 1799 | $2.97 | 5,777.0000 | 56,644,223 | 45.22% | 0.00% |
| March 31, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | P | Common Stock | 2107 | $2.54 | 3,978.0000 | 56,644,223 | 112.61% | 0.00% |
| Jan. 1, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | M | Common Stock | 249 | $0.00 | 1,871.0000 | 56,644,223 | 15.35% | 0.00% |
| Jan. 1, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | M | Restricted Stock Units | 249 | $0.00 | 0.0000 | 56,644,223 | 100.00% | 0.00% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | A | Stock Options (Right to Buy) | 288000 | $0.00 | 288,000.0000 | 5,269,240 | 9999.99% | 5.47% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | A | Restricted Stock Units | 96000 | $0.00 | 96,000.0000 | 5,269,240 | 9999.99% | 1.82% |
| July 24, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | A | Restricted Stock Units | 1659185 | $0.00 | 1,672,087.0000 | 5,269,240 | 9999.99% | 31.49% |
| April 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | M | Common Stock | 15059 | $0.00 | 43,605.0000 | 5,269,240 | 52.75% | 0.29% |
| April 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | F | Common Stock | 3311 | $0.41 | 40,294.0000 | 5,269,240 | 7.59% | 0.06% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | A | Restricted Stock Units | 3233 | $0.00 | 24,728.0000 | 0 | 15.04% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | A | Restricted Stock Units | 404 | $0.00 | 27,961.0000 | 0 | 1.47% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | M | Common Stock | 644 | $0.00 | 28,771.0000 | 0 | 2.29% | 0.00% |
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | F | Common Stock | 368 | $2.79 | 28,127.0000 | 0 | 1.29% | 0.00% |
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | M | Common Stock | 1675 | $0.00 | 28,495.0000 | 0 | 6.25% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | A | Restricted Stock Units | 2425 | $0.00 | 27,153.0000 | 0 | 9.81% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | A | Restricted Stock Units | 404 | $0.00 | 27,557.0000 | 0 | 1.49% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | F | Common Stock | 225 | $1.71 | 28,546.0000 | 0 | 0.78% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | M | Restricted Stock Units | 1675 | $0.00 | 22,139.0000 | 0 | 7.03% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | F | Common Stock | 368 | $2.79 | 28,126.0000 | 0 | 1.29% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Bigora Sian | Chief Development Officer | M | Common Stock | 1675 | $0.00 | 28,494.0000 | 0 | 6.25% | 0.00% |